Sopharma Trading AD Balance Sheet Health
Financial Health criteria checks 5/6
Sopharma Trading AD has a total shareholder equity of BGN157.6M and total debt of BGN219.4M, which brings its debt-to-equity ratio to 139.2%. Its total assets and total liabilities are BGN796.6M and BGN639.0M respectively. Sopharma Trading AD's EBIT is BGN53.4M making its interest coverage ratio 6.2. It has cash and short-term investments of BGN13.2M.
Key information
139.2%
Debt to equity ratio
лв219.38m
Debt
| Interest coverage ratio | 6.2x |
| Cash | лв13.24m |
| Equity | лв157.58m |
| Total liabilities | лв639.03m |
| Total assets | лв796.60m |
Recent financial health updates
No updates
Recent updates
We're Not Counting On Sopharma Trading AD (BUL:SO5) To Sustain Its Statutory Profitability
Feb 14
If You Had Bought Sopharma Trading AD's (BUL:SO5) Shares Three Years Ago You Would Be Down 27%
Dec 18We Wouldn't Rely On Sopharma Trading AD's (BUL:SO5) Statutory Earnings As A Guide
Aug 10
Sopharma Trading AD's (BUL:SO5) Shareholders Are Down 35% On Their Shares
Jul 20Financial Position Analysis
Short Term Liabilities: SFT's short term assets (BGN599.4M) exceed its short term liabilities (BGN552.9M).
Long Term Liabilities: SFT's short term assets (BGN599.4M) exceed its long term liabilities (BGN86.1M).
Debt to Equity History and Analysis
Debt Level: SFT's net debt to equity ratio (130.8%) is considered high.
Reducing Debt: SFT's debt to equity ratio has reduced from 323.4% to 139.2% over the past 5 years.
Debt Coverage: SFT's debt is well covered by operating cash flow (27.2%).
Interest Coverage: SFT's interest payments on its debt are well covered by EBIT (6.2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 07:59 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sopharma Trading AD is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mihail Dimitrov | First Financial Brokerage House |